Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
Lara Herrera, Myriam Martin‐Inaraja, Silvia J. Santos, et al.
Immunology (2021) Vol. 165, Iss. 2, pp. 234-249
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 57
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, et al.
Future Virology (2023) Vol. 18, Iss. 3, pp. 177-191
Open Access | Times Cited: 26
Phenotypic Heterogeneity of Dysfunctional Natural Killer Cells During Chronic Infection or Cancer
Kévin Pouxvielh, Marie Marotel, Noëmi Rousseaux, et al.
Springer eBooks (2025), pp. 1-31
Closed Access
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
Exploring the Utility of NK Cells in COVID-19
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1002-1002
Open Access | Times Cited: 20
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 537-537
Open Access | Times Cited: 10
Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19
Maria O. Ustiuzhanina, Julia D. Vavilova, Anna A. Boyko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1996-1996
Open Access | Times Cited: 9
Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection
Maren Claus, Naomi Pieris, Doris Urlaub, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
Jacob C. Bjorgen, Jenna K. Dick, Ross Cromarty, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri‐Bowen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi, et al.
Pilot and Feasibility Studies (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Innate Immune Cell Functions Contribute to Spontaneous HIV Control
Andrea B. Huber, Frank Baas, Andre J. A. M. van der Ven, et al.
Current HIV/AIDS Reports (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Role of natural killer and B cell interaction in inducing pathogen specific immune responses
Nikunj Tandel, Sushmita Negi, Sarat K. Dalai, et al.
International Reviews of Immunology (2023) Vol. 42, Iss. 4, pp. 304-322
Closed Access | Times Cited: 4
Analysis of the impact of handling and culture on the expansion and functionality of NK cells
Sara Martin-Iglesias, Lara Herrera, Silvia Santos, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection
Juan Bautista De Sanctis, Jenny Garmendia, Marián Hajdúch
Immuno (2022) Vol. 2, Iss. 1, pp. 52-67
Open Access | Times Cited: 5
Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
Karima Al‐Akioui‐Sanz, B. Pascual-Miguel, Mariana Díaz‐Almirón, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 330-340
Open Access | Times Cited: 4
Characteristics and Potential Roles of Natural Killer Cells During SARS-CoV-2 Infection
Wen-Jing Cao, Fu‐Sheng Wang, Jin‐Wen Song
Infectious Diseases & Immunity (2022) Vol. 3, Iss. 1, pp. 29-35
Open Access | Times Cited: 3
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID
Maddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Innate Lymphoid Cells in COVID-19: Bystanders or Active Contributors?
Min‐Jong Kang, Soyeon Kwon, Seungwon Ryu
Journal of Bacteriology and Virology (2024) Vol. 54, Iss. 4, pp. 284-296
Open Access
A Phase I, Dose-Escalation Clinical Trial to Evaluate the Safety of Infusing Natural Killer Cells as Adoptive Therapy in COVID-19: Release
Clara Hernández-Blanco, Karima Al‐Akioui‐Sanz, Lara Herrera del Val, et al.
(2024)
Closed Access
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Cytokines and inflammation (2024) Vol. 20, Iss. 4, pp. 49-66
Open Access
Emerging Insights into Memory Natural Killer Cells and Clinical Applications
Jonida Kokiçi, Anucha Preechanukul, Helena Arellano-Ballestero, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1746-1746
Open Access
The Antigen‐Specific Response of NK Cells to SARS‐CoV‐2 Correlates With KIR2DS4 Expression
Maria O. Ustiuzhanina, Anna A. Boyko, Julia D. Vavilova, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 11
Closed Access
Page 1 - Next Page

Scroll to top